An integrative view on the role of TGF-Β in the progressive tubular deletion associated with chronic kidney disease

Kidney International

Volumn 77, Issue 11, 2012, Pages 950-955

  García Sánchez, Omar ^a,b   López Hernández, Francisco J ^a,b,c   López Novoa, José M ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Instituto Reina Sofía de Investigación Nefrológica Fundación Iñigo Álvarez de Toledo   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

apoptosis; chronic renal disease; epithelial to mesenchymal transition; fibrosis; TGF ; tubular deletion

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL CYCLE ARREST; CHRONIC KIDNEY DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE TUBULAR DELETION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSDIFFERENTIATION; CHRONIC DISEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROSIS; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL TRANSDIFFERENTIATION; CHRONIC DISEASE; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77955877792     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.88     Document Type: Short Survey

References (43)

1. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296. (Pubitemid 43228342)
2. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and endstage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14(Suppl 6): 31-41. (Pubitemid 29462212)
3. Massagué J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644.
4. Siegel PM, Massagué J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807-820. (Pubitemid 37376979)
5. Li Y, Tan X, Dai C et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 1907-1918.
6. Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009; 1: 303-314.
7. Ishibe S, Cantley LG. Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 2008; 17: 379-385.
8. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12. (Pubitemid 38020692)
9. Xie L, Law BK, Chytil AM et al. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 2004; 6: 603-610. (Pubitemid 39411098)
10. Rodŕguez-Peñ a AB, Grande MT, Eleno N et al. Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int 2008; 74: 196-209. (Pubitemid 351915085)
11. Grande MT, Fuentes-Calvo I, Arévalo M et al. Targeted disruption of H-Ras decreases renal fibrosis after ureteral obstruction in mice. Kidney Int 2010; 77: 509-518.
12. Grande MT, Arévalo M, Núñ ez A et al. Targeted genomic disruption of Hras and N-ras has no effect on early renal changes after unilateral ureteral ligation. World J Urol 2009; 27: 787-797.
13. Grande MT, Ló pez-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009; 5: 319-328.
14. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968. (Pubitemid 36889942)
15. Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 2005; 16: 68-78. (Pubitemid 43073158)
16. Masszi A, Fan L, Rosivall L et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004; 165: 1955-1967. (Pubitemid 39578374)
17. Miyajima A, Chen J, Lawrence C et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301-2313.
18. Bhaskaran M, Reddy K, Radhakrishanan N et al. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Ren Physiol 2003; 284: F955-F965. (Pubitemid 36443580)
19. Docherty NG, O'Sullivan OE, Healy DA et al. TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 2006; 290: F1202-F1212. (Pubitemid 43724921)
20. Dai C, Yang J, Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 2003; 278: 12537-12545. (Pubitemid 36800243)
21. Tian M, Schiemann WP. The TGF-beta paradox in human cancer: an update. Future Oncol 2009; 5: 259-271.
22. Nicolás FJ, Lehmann K, Warne PH et al. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by downregulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. J Biol Chem 2003; 278: 3251-3256. (Pubitemid 36801237)
23. Counts RS, Nowak G, Wyatt RD et al. Nephrotoxicant inhibition of renal proximal tubule cell regeneration. Am J Physiol 1995; 269: F274-F281.
24. Ferraccioli G, Romano G. Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors. Lupus 2008; 17: 533-540. (Pubitemid 351955428)
25. Khan S, Koepke A, Jarad G et al. Apoptosis and JNK activation are differentially regulated by Fas expression level in renal tubular epithelial cells. Kidney Int 2001; 60: 65-76. (Pubitemid 32587540)
26. Jarad G, Wang B, Khan S et al. Fas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis. J Biol Chem 2002; 277: 47826-47833. (Pubitemid 36159309)
27. Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388-1396. (Pubitemid 27239888)
28. Tamaki K, Okuda S. Role of TGF-beta in the progression of renal fibrosis. Contrib Nephrol 2003; 139: 44-65.
29. Strutz F, Neilson EG. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol 2003; 24: 459-476.
30. Lenda DM, Kikawada E, Stanley ER et al. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 2003; 170: 3254-3262. (Pubitemid 36302203)
31. Schull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-b1 gene results in multifocal inflammatory disease. Nature (Lond) 1992; 359: 693-699.
32. Kulkarni AB, Huh CG, Becker D et al. Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90: 770-774. (Pubitemid 23028947)
33. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
34. Zeisberg M, Kalluri R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol 2008; 23: 1395-1398.
35. Marastoni S, Ligresti G, Lorenzon E et al. Extracellular matrix: a matter of life and death. Connect Tissue Res 2008; 49: 203-206.
36. Mooney A, Jackson K, Bacon R et al. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrinmediated survival signals. Am J Pathol 1999; 155: 599-606. (Pubitemid 29370409)
37. Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int 2000; 58(Suppl 77): S67-S75.
38. Arnould C, Lelièvre-Pégorier M, Ronco P et al. MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development. J Am Soc Nephrol 2009; 20: 2171-2180.
39. Kassiri Z, Oudit GY, Kandalam V et al. Loss of TIMP3 enhances interstitial nephritis and fibrosis. J Am Soc Nephrol 2009; 20: 1223-1235.
40. Boudreau N, Werbt Z, Bissell MJ. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Nat Acad Sci USA 1996; 93: 3509-3513. (Pubitemid 26125651)
41. Haase VH. Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann NY Acad Sci 2009; 1177: 57-65.
42. Chanson M, Derouette JP, Roth I et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 2005; 1711: 197-207. (Pubitemid 40799294)
43. Gould SE, Day M, Jones SS et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60. (Pubitemid 34075130)